Tempus exhibits 4 abstracts at the 2025 american college of cardiology annual meeting

Chicago--(business wire)--tempus ai, inc. (nasdaq: tem), a technology company leading the adoption of ai to advance precision medicine and patient care, today announced the company is scheduled to exhibit 4 abstracts at the american college of cardiology (acc) annual meeting, which convenes from march 29-31 in chicago, illinois. this is the first year that tempus is presenting research, all of which highlights the application of ai to support clinicians in delivering personalized care. “tempus.
TEM Ratings Summary
TEM Quant Ranking